ATE358128T1 - Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation - Google Patents
Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitationInfo
- Publication number
- ATE358128T1 ATE358128T1 AT01902793T AT01902793T ATE358128T1 AT E358128 T1 ATE358128 T1 AT E358128T1 AT 01902793 T AT01902793 T AT 01902793T AT 01902793 T AT01902793 T AT 01902793T AT E358128 T1 ATE358128 T1 AT E358128T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- preventive
- therapeutic agents
- agents against
- against gastric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000031542 | 2000-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE358128T1 true ATE358128T1 (de) | 2007-04-15 |
Family
ID=18556282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01902793T ATE358128T1 (de) | 2000-02-09 | 2001-02-07 | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation |
Country Status (13)
Country | Link |
---|---|
US (7) | US6967207B2 (de) |
EP (1) | EP1256581B1 (de) |
JP (1) | JP4781592B2 (de) |
KR (1) | KR100750437B1 (de) |
AT (1) | ATE358128T1 (de) |
AU (1) | AU2001230588A1 (de) |
CA (1) | CA2399818C (de) |
DE (1) | DE60127535T2 (de) |
DK (1) | DK1256581T3 (de) |
ES (1) | ES2284612T3 (de) |
PT (1) | PT1256581E (de) |
TW (1) | TWI256314B (de) |
WO (1) | WO2001058898A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI256314B (en) * | 2000-02-09 | 2006-06-11 | Mitsubishi Pharma Corp | Preventive-therapeutical medicament for gastroesophageal reflux disease |
DE60221402T2 (de) * | 2001-08-24 | 2008-04-03 | Mitsubishi Pharma Corp. | Mittel zur prävention und behandlung des vorwiegend durch obstipation geprägten reizdarms |
WO2003020728A1 (en) | 2001-08-30 | 2003-03-13 | Pharmacia & Upjohn Company | 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS |
EA007429B1 (ru) * | 2001-10-02 | 2006-10-27 | Фармация Энд Апджон Компани | Азабициклические замещённые конденсированные гетероарильные соединения |
AR038117A1 (es) | 2002-01-14 | 2004-12-29 | Upjohn Co | Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida |
AR038118A1 (es) | 2002-01-14 | 2004-12-29 | Upjohn Co | Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales |
AR038294A1 (es) * | 2002-01-14 | 2005-01-12 | Upjohn Co | Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales |
JP2007507425A (ja) * | 2003-08-29 | 2007-03-29 | ダイノゲン ファーマシューティカルズ,インコーポレイテッド | 胃腸管運動障害を処置するために有用な組成物 |
US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
CA2690581A1 (en) * | 2007-06-07 | 2008-12-18 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastroesophageal reflux disease |
MX2012000572A (es) * | 2009-07-14 | 2012-05-08 | Albany Molecular Res Inc | Moduladores del receptor 5-hidroxi triptamina 3 (5-ht3), metodos para su realización y uso de los mismos. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4829073A (en) * | 1988-05-12 | 1989-05-09 | Bristol-Myers Company | Thiadiazole oxides for treating gastrointestinal motility disorders |
CA2028002A1 (en) * | 1989-10-19 | 1991-04-20 | Daniel P. Becker | Method of treating gastrointestinal motility disorders |
JP2699794B2 (ja) * | 1992-03-12 | 1998-01-19 | 三菱化学株式会社 | チエノ〔3,2−b〕ピリジン誘導体 |
SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
TWI256314B (en) * | 2000-02-09 | 2006-06-11 | Mitsubishi Pharma Corp | Preventive-therapeutical medicament for gastroesophageal reflux disease |
-
2001
- 2001-02-05 TW TW090102372A patent/TWI256314B/zh not_active IP Right Cessation
- 2001-02-07 DK DK01902793T patent/DK1256581T3/da active
- 2001-02-07 ES ES01902793T patent/ES2284612T3/es not_active Expired - Lifetime
- 2001-02-07 DE DE60127535T patent/DE60127535T2/de not_active Expired - Lifetime
- 2001-02-07 PT PT01902793T patent/PT1256581E/pt unknown
- 2001-02-07 JP JP2001558448A patent/JP4781592B2/ja not_active Expired - Fee Related
- 2001-02-07 WO PCT/JP2001/000852 patent/WO2001058898A1/ja active IP Right Grant
- 2001-02-07 US US10/203,278 patent/US6967207B2/en not_active Expired - Fee Related
- 2001-02-07 KR KR1020027010059A patent/KR100750437B1/ko not_active IP Right Cessation
- 2001-02-07 EP EP01902793A patent/EP1256581B1/de not_active Expired - Lifetime
- 2001-02-07 AT AT01902793T patent/ATE358128T1/de not_active IP Right Cessation
- 2001-02-07 CA CA002399818A patent/CA2399818C/en not_active Expired - Fee Related
- 2001-02-07 AU AU2001230588A patent/AU2001230588A1/en not_active Abandoned
-
2005
- 2005-08-31 US US11/214,818 patent/US20050282852A1/en not_active Abandoned
-
2006
- 2006-08-21 US US11/507,010 patent/US20060281781A1/en not_active Abandoned
-
2008
- 2008-07-29 US US12/219,806 patent/US20080293762A1/en not_active Abandoned
-
2009
- 2009-09-22 US US12/564,650 patent/US20100168157A1/en not_active Abandoned
- 2009-09-23 US US12/565,261 patent/US20100210679A1/en not_active Abandoned
- 2009-10-09 US US12/588,307 patent/US20100204267A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060281781A1 (en) | 2006-12-14 |
CA2399818C (en) | 2010-01-12 |
EP1256581B1 (de) | 2007-03-28 |
AU2001230588A1 (en) | 2001-08-20 |
US20100204267A1 (en) | 2010-08-12 |
US20100210679A1 (en) | 2010-08-19 |
PT1256581E (pt) | 2007-06-26 |
KR20020089340A (ko) | 2002-11-29 |
US6967207B2 (en) | 2005-11-22 |
TWI256314B (en) | 2006-06-11 |
DE60127535T2 (de) | 2007-12-06 |
DE60127535D1 (de) | 2007-05-10 |
US20050282852A1 (en) | 2005-12-22 |
DK1256581T3 (da) | 2007-09-24 |
CA2399818A1 (en) | 2001-08-16 |
US20100168157A1 (en) | 2010-07-01 |
JP4781592B2 (ja) | 2011-09-28 |
US20030130304A1 (en) | 2003-07-10 |
EP1256581A1 (de) | 2002-11-13 |
ES2284612T3 (es) | 2007-11-16 |
KR100750437B1 (ko) | 2007-08-21 |
EP1256581A4 (de) | 2004-10-06 |
US20080293762A1 (en) | 2008-11-27 |
WO2001058898A1 (fr) | 2001-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1094191A1 (en) | Phenyl-carboxamide compounds useful for treating pain | |
ATE440603T1 (de) | 8-hydroxychinolinderivate | |
NO20055655L (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
NO20071042L (no) | 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer | |
IL205420A (en) | Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders | |
BR0114870A (pt) | Tratamento de tumores estromais gastrointestinais | |
EP1065204A4 (de) | Bicyclische Carbonyl-Indolverbindungen als entzündungshemmende/ analgetische Wirkstoffe und als COX-2 Inhibitoren | |
ATE358128T1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
RU2004103475A (ru) | Производные арил-или гетероарилазолилкарбинолов для лечения недержания мочи | |
RU98119076A (ru) | Производные 2-(3h)-оксазолона и их применение в качестве ингибиторов сох-2 | |
EP1152004A4 (de) | Derivate der phosphonsäure zur inhibierung von carboxypeptidase b | |
NO20025659D0 (no) | Heterocykliske forbindelser | |
IL150965A0 (en) | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative | |
DE60203844D1 (de) | Verwendung von Hydantoin und seinen Derivaten gegen Hypalbuminämie | |
DE60126199D1 (de) | Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen | |
WO2007000392A3 (en) | Chloro-substituted guanidines | |
ATE511395T1 (de) | Mittel zur behandlung von glomerulopathie | |
HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEIH | Change in the person of patent owner | ||
UEP | Publication of translation of european patent specification |
Ref document number: 1256581 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |